Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | ...

Novo Nordisk is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply ...

Earlier, Novo Nordisk A/S (NYSE:NVO) petitioned the FDA to ban compounding pharmacies from producing cheaper, unapproved ...

Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...

COPENHAGEN--Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb ... for a 0.25-milligram starter dose and 42,960 yen for a 2.4 mg dose, Novo said.

Hims & Hers offers compounded Wegovy for $99 a month to select professions ... on Tuesday it has begun selling vials of the lowest starter dose of its popular weight-loss drug Zepbound in the ...

He said that the slower pace of weekly prescriptions for Wegovy in the United States in the last couple of months was due to lower starter doses being supplied into the market. "You can find ...